Private Capital Advisory Publications

Secondaries Market Year-End Review & 2023 Outlook Survey

SECONDARIES

Q1 2023

Request Paper

Secondaries Market Year-End Review & 2022 Outlook Survey

SECONDARIES

Q1 2022

Request Paper

H1 2022 Limited Partners Survey

PLACEMENTS

April 2022

Request Paper

Secondaries Market Year-End Review & 2021 Outlook Survey

SECONDARIES

Q1 2021

Request Paper

Q1 2020 Secondaries Buyers Survey

SECONDARIES

Q1 2020

Request Paper

H1 2020 Limited Partners Survey

PLACEMENTS

May 2020

Request Paper

Secondaries Market Outlook 2018

SECONDARIES

Q1 2018

Request Paper

Secondaries Market Outlook 2017

SECONDARIES

Q1 2017

Request Paper

Secondaries Market Outlook 2016

SECONDARIES

Q1 2016

Request Paper

Fund Raising Lessons for Lower Mid-Market Funds

PLACEMENTS

October 2015

Request Paper

European Family Offices as Private Equity Investors

PLACEMENTS

March 2015

Request Paper

Most Demanded Secondaries of 2014

SECONDARIES

January 2015

Request Paper

Industry Insight

To select your areas of interest and begin receiving our insights and other updates, click sign up below.

Get in touch

Raymond James | Cebile Capital is a leading private equity placement agent and secondary market advisor, working with world-class general partners on a global basis. We welcome all inquiries and look forward to hearing from you.

Recent News

Investment Banking  |  August 15, 2023

Raymond James hires two senior bankers to Healthcare investment banking practice

Read more about Raymond James hires two senior bankers to Healthcare investment banking practice
Investment Banking  |  July 10, 2023

Raymond James hires veteran senior medical technology banker, continuing Healthcare Investment Banking practice momentum

Read more about Raymond James hires veteran senior medical technology banker, continuing Healthcare Investment Banking practice momentum
Equity Research  |  June 15, 2023

Raymond James hires Gary Nachman as senior life sciences analyst

Read more about Raymond James hires Gary Nachman as senior life sciences analyst